0001209191-18-043131.txt : 20180718
0001209191-18-043131.hdr.sgml : 20180718
20180718174437
ACCESSION NUMBER: 0001209191-18-043131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180716
FILED AS OF DATE: 20180718
DATE AS OF CHANGE: 20180718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18959139
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2018-07-16
4
M
0
860
96.87
A
16947
D
Common Stock
2018-07-16
4
S
0
860
179.85
D
16087
D
Common Stock
169
I
401(k)
Stock Option (Right to Buy)
96.87
2018-07-16
4
M
0
860
0.00
D
2024-07-14
Common Stock
860
0
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Fully vested.
/s/ Stephen Miguasky, Attorney-in-Fact
2018-07-18